alexa The role of PI-3 kinase in cancer biology and approaches to the therapeutics of cancer
ISSN: 0974-8369

Biology and Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

The role of PI-3 kinase in cancer biology and approaches to the therapeutics of cancer

 
To read the full article Peer-reviewed Article PDF image

Abstract

Many types of immune cellular stimulation or toxic insults activate the generalized systemic PI3K/AKT pathway and it regulates the basic cellular functions such as transcription, proliferation, growth and survival. The modified and disturbed activation of these pathway result in development of major disease such as cancer, diabetes mellitus and autoimmune disorders. Especially, PI3K/AKT mediated signal transduction molecules and effects on gene expression that contribute to tumorigenesis. Current evidence has suggested that the PI3K/AKT pathway is visible target for novel antitherapeutic drugs. Importantly, the main objectives of the signal transduction based research are to develop effective, low cost chemotherapeutic drugs that target very dangerous cancerous cells without affecting the normal cells. Small interfering RNA (siRNA) is one of the very effective therapeutic models in cancerous gene to inhibit or mimic the PI3K/AKT pathway for anticancer treatment. Many biological, active chemotherapeutic drugs have developed to inhibit the PI3K/AKT signaling pathways. This review will focus on the PI3K/AKT pathways, its alteration in cancer progression and different chemotherapeutic drugs have been used to inhibit the different types of cancer.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords